Palestine News

GLP-1 receptor agonist use does not increase insulin discontinuation with type 2 diabetes

Written by

wpadmin

in

For veterans with type 2 diabetes (T2D) receiving basal insulin therapy, the addition of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) does not increase the rate of…

Continue Reading


News Source: medicalxpress.com

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *

More posts